Clinical Trials Logo
NCT number NCT03357965
Study type Observational
Source Umraniye Education and Research Hospital
Contact
Status Completed
Phase N/A
Start date December 1, 2016
Completion date February 1, 2017

Clinical Trial Summary

Maternal bonding was described as a qualitative change in the relationship of a mother with her infant. By this study, the investigators aimed to investigate the mother-infant bonding and the factors affecting it, from the point of the family practice, which is responsible for the healthcare of all family members from the fetus to the eldest individual in a family.


Clinical Trial Description

The study was carried out as a single-centered descriptive research among 73 women at the postpartum period. The sociodemographic status and the histories of pregnancies of the study participants were recorded. The Maternal Attachment Inventory (MAI), which questions the biological, psychological and social factors, and the Hospital Anxiety and Depression Scale (HADS) were used to collect data to determine the factors affecting the mother-infant bonding in the postpartum period.

The study is a descriptive survey study, which was conducted to determine the mother-infant attachment and its affecting factors in mothers in the first 6-week of the postpartum period. In order to conduct the study, the local Ethics Committee approval was obtained. (Approval date: 24.11.2016, number 18517).

The mean score of the Turkish version of the Maternal Attachment Inventory (MAI) is approximately 95+6 according to the validation study. In our study, considering that the average MAI score of the participants would be approximately 97, investigators determined to include 73 patients in the study with a type I error set at a=0.05 and with the power of (1-b) 80%.

The universe of the study consists of the mothers in the first 6 weeks of the postpartum period presenting to the Obstetrics and Gynecology Clinic and the mothers of the pediatric patients presenting to the Pediatric Clinic of the Health Sciences University Umraniye Education and Research Hospital.


Study Design


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran for Depression in Palliative Care Phase 2/Phase 3
Recruiting NCT03167372 - Pilot N-of-1 Light Therapy Study N/A
Enrolling by invitation NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Enrolling by invitation NCT03272555 - WILD 5 Wellness: A 30-Day Intervention N/A
Not yet recruiting NCT03234439 - Digital Tools for Coping With Chronic Pain N/A
Recruiting NCT02543983 - Neurobiology of Suicide Phase 2
Recruiting NCT03129204 - Sensation Awareness Focused Training for Spouses N/A
Completed NCT01198197 - PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A Early Phase 1
Recruiting NCT00024635 - Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers N/A
Recruiting NCT03149991 - A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) Phase 4
Not yet recruiting NCT03196544 - Novel Behavioral Intervention to Enhance Social Connections in Anxiety and Depression N/A
Not yet recruiting NCT03293797 - Ultra-Brief Intervention to Reduce Depressive and Anxious Symptoms N/A
Not yet recruiting NCT03254719 - Care Outcomes for Chiropractic Outpatient Veterans N/A
Recruiting NCT02953990 - Self-Management of Chronic Depressive Symptoms in Pregnancy N/A
Recruiting NCT03004872 - Relationship Between Postpartum Mood Disorders and Delivery Experience N/A
Recruiting NCT02924090 - Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression Phase 4
Recruiting NCT02987582 - A Feasibility Study of an Emotion-Focused Mindfulness Group N/A
Recruiting NCT02981381 - Synchronized Transcranial Magnetic Stimulation for PTSD Phase 2
Recruiting NCT02911597 - Double-Blind, Cross-Over Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD) Phase 1